(R)- and (S)-[11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

Alfred H. Schinkel, Jasper Smit, Olaf van Tellingen et al. · Cell · 1994 · 2.3K citations

Molecular Pharmacology, Medicine, P-glycoprotein Gene +6

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

Alfred H. Schinkel, Els Wagenaar, Carla A.A.M. Mol et al. · Journal of Clinical Investigation · 1996 · 1.3K citations · Full text

Oral Loperamide, Brain Penetration, Pharmacotherapy +20

β‐Amyloid efflux mediated by p‐glycoprotein

Fred C. Lam, Ronghua Liu, Peihua Lu et al. · Journal of Neurochemistry · 2001 · 373 citations

Deposition of Alzheimer's ??-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans

Silke Vogelgesang, Ingolf Cascorbi, Eike Schroeder et al. · Pharmacogenetics · 2002 · 339 citations

Aging, Vascular P-gp Expression, Neurochemical Biomarkers +18

Identification of P450 enzymes involved in metabolism of verapamil in humans

H. Kroemer, Jean‐Charles Gautier, Philippe Beaune et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1993 · 202 citations

Molecular Pharmacology, Biochemistry, Medicine +8